Clinical Study
Utility of Serum Neopterin and Serum IL-2 Receptor Levels to Predict Absolute CD4 T Lymphocyte Count in HIV Infected Cases
Table 2
Change in the level of markers from baseline to followup in the three groups.
| Marker | Group A (CD4 < 200) | Group B (200–500) | Group C (>500) | Baseline Median (IQR) | FU Median (IQR) | P value | Baseline Median (IQR) | FU Median (IQR) | P value | Baseline Median (IQR) | FU Median (IQR) | P value |
| CD4 count (cells/µL) | 111 (79–154) | 216 (159–253) | 0.000 | 305 (259–392) | 274 (200–406) | 0.162 | 580 (524–750) | 487 (383–576) | 0.008 | S. neopterin (nmol/L) | 38.6 (27.5–128.1) | 11.2 (8.13–21) | 0.00 | 22.9 (13.4–40.3) | 37.1 (16.6–63.3) | 0.003 | 16.2 (10.3–23) | 27.6 (19.2–43.1) | 0.001 | sIL-2R (pM) | 96.1 (61.4–139.1) | 45.5 (26.7–65.2) | 0.000 | 60.9 (40.9–86.8) | 77.8 (56.9–98.2) | 0.017 | 35.1 (25.2–64.6) | 53.1 (37.5–84.9) | 0.004 |
|
|